论文信息 - Monosomy 13 in metaphase spreads is a predictor of poor long-term outcome after bortezomib plus dexamethasone treatment for relapsed/refractory multiple myeloma - 字舞流文

Monosomy 13 in metaphase spreads is a predictor of poor long-term outcome after bortezomib plus dexamethasone treatment for relapsed/refractory multiple myeloma

M. Taniwaki | S. Horiike | J. Kuroda | Y. Shimura | M. Yamamoto-Sugitani | N. Sasaki | M. Ohshiro | H. Uchiyama | C. Shimazaki | Yosuke Matsumoto | Y. Chinen | Tsutomu Kobayashi | H. Nagoshi | M. Kiyota | S. Fuchida | S. Mizutani | Natsumi Sakamoto | Ryuko Nakayama